Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The SARS-CoV-2 Mu variant should not be left aside: It warrants attention for its immuno-escaping ability.

Journal of medical virology - 1 Jun 2022

Pascarella Stefano, Bianchi Martina, Giovanetti Marta, Narzi Daniele, Cauda Roberto, Cassone Antonio, Ciccozzi Massimo

Abstract excerpt

The COVID-19 pandemic continues to have a threatening impact on a global scale, largely due to the emergence of newly SARS-CoV-2 variants. The Mu (PANGO lineage B.1.621), was first identified in Colombia in January 2021 and was classified as a variant of interest (VOI) in August 2021, due to a constellation of mutations that likely-mediate an unexpectedly enhanced immune resistance to inactivated vaccine-elicited...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Attention
Share to COVID-19

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to COVID-19 Vaccines

Share to Mutation

Share to Pandemics

Share to SARS-CoV-2

Share to Spike Glycoprotein, Coronavirus

Source

Open in PubMed Open full text

Identifiers

PMID: 35174519
DOI: 10.1002/jmv.27663
PMCID: PMC9088528

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The SARS-CoV-2 Mu variant should not be left aside: It warrants attention for its immuno-escaping ability.PMID 35174519Read ↗

Low neutralizing antibody titers against the Mu variant of SARS-CoV-2 in BNT162b2 vaccinated individualsSemantic proximity Read ↗

Delta variant (B.1.617.2) of SARS-CoV-2: current understanding of infection, transmission, immune escape, and mutational landscape.Semantic proximity Read ↗

Characterization of the emerging B.1.621 variant of interest of SARS-CoV-2.Semantic proximity Read ↗

Characterization of the emerging B.1.621 variant of interest of SARS-CoV-2Semantic proximity Read ↗

Delta variant (B.1.617.2) of SARS-CoV-2: Mutations, impact, challenges and possible solutions.Semantic proximity Read ↗

Severity, Pathogenicity and Transmissibility of Delta and Lambda Variants of SARS-CoV-2, Toxicity of Spike Protein and Possibilities for Future Prevention of COVID-19Semantic proximity Read ↗

Omicron BA.2 Lineage, the “Stealth” Variant: Is It Truly a Silent Epidemic? A Literature ReviewSemantic proximity Read ↗

Emergence and spread of the potential variant of interest (VOI) B.1.1.519 of SARS-CoV-2 predominantly present in Mexico.Semantic proximity Read ↗

Description of a One-Year Succession of Variants of Interest and Concern of SARS-CoV-2 in Venezuela.Semantic proximity Read ↗

DIVERSITY AND CLINICAL CORRELATIONS OF SARS-CoV-2 VARIANT DURING THE INTRODUCTION OF THE DELTA VARIANT IN GUATEMALASemantic proximity Read ↗

DIVERSITY AND CLINICAL CORRELATIONS OF SARS-CoV-2 VARIANT DURING THE INTRODUCTION OF THE DELTA VARIANT IN GUATEMALASemantic proximity Read ↗

SARS-CoV-2 variant Delta rapidly displaced variant Alpha in the United States and led to higher viral loadsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.